Comparisons13 min readUpdated 2026-04-09

    Mochi Health vs Trimi vs Henry Meds: Best Compounded GLP-1 Provider

    Mochi Health vs Trimi vs Henry Meds compared for price, clinical support, pharmacy quality, and patient experience. Find the best compounded GLP-1 provider for your needs in 2026.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. Pricing verified April 2026.

    Quick links: Semaglutide $99/mo, Tirzepatide $125/mo, Hims vs Ro vs Trimi comparison.

    Three Platforms, Three Different Approaches

    Mochi Health, Trimi, and Henry Meds are all telehealth platforms providing compounded semaglutide and tirzepatide directly to patients. But they've built very different models around the same core medication. Understanding those model differences is more useful than comparing headline prices — because the headline price rarely tells the full story.

    Mochi Health has built a high-touch, bundled experience with dietitians, health coaches, and behavioral programming wrapped around the medication. Henry Meds competes primarily on low advertised entry pricing. Trimi's model is built on flat-rate specialist care — weight-loss-focused clinicians, no membership fees, and the same price at every dose level.

    This comparison covers what actually matters for a 12-to-18-month treatment course: total cost, pharmacy quality, clinical expertise, and the type of support each platform provides. For a broader view of the market, see our top 10 compounded GLP-1 providers ranking.

    Side-by-Side Comparison

    FeatureMochi HealthTrimiHenry Meds
    Semaglutide Price$149–$249/mo (incl. membership)$99/mo flat~$69–$99/mo
    Tirzepatide Price$199–$299/mo$125/mo flat~$99–$149/mo
    Membership FeeYes — included in bundleNo separate feePlan fee applies
    Pricing ModelBundled membershipFlat rate all dosesDose-variable
    Dietitian AccessIncludedClinical guidanceLimited
    Coaching/BehavioralYes — includedClinical focusMinimal
    Platform FocusComprehensive wellnessGLP-1 specialistMedication access
    ContractVaries by planMonth-to-monthMonth-to-month

    Mochi Health: Comprehensive But Pricier

    Mochi Health differentiates itself by wrapping significant support infrastructure around its GLP-1 prescribing. Members get access to registered dietitians, health coaches, and behavioral programming — a model designed to address the lifestyle factors that influence long-term weight maintenance alongside the medication.

    The trade-off is cost. Mochi's membership model makes it the most expensive of the three platforms when you account for the full monthly spend. For patients who will actively use the dietitian and coaching resources, the premium may be justified. For patients who primarily need the medication with competent medical oversight — the majority — paying Mochi's premium for services you may rarely use is hard to justify when Trimi provides equivalent clinical oversight at $99 to $125 per month.

    Comprehensive support including dietitian and health coach access

    Strong behavioral and lifestyle programming

    Good for patients who want high-touch holistic weight management

    Higher total monthly cost than Trimi or Henry Meds

    You're paying for support services even if you don't use them

    Membership model is less flexible for patients who just need medication

    Henry Meds: Low Entry Price, Variable Total Cost

    Henry Meds attracts attention with some of the lowest advertised semaglutide prices in the market. The entry price point — around $69/month at starter doses — genuinely is low, and for patients who remain at lower dose levels, it can be a cost-effective option.

    The concern is what happens as dose escalates. Henry Meds's pricing structure is more variable, and patients who progress to therapeutic maintenance doses may find their costs increasing. The platform is also more oriented toward medication access than intensive clinical support — follow-up protocols are less structured than Trimi's or Mochi's.

    For patients who want to minimize upfront cost and are comfortable with less hand-holding, Henry Meds can work. For patients who want cost predictability across the full treatment course, Trimi's flat-rate model is more reliable. See our guide to GLP-1 programs under $100/month for more budget-oriented options.

    Trimi: Flat Rate, Specialist Focus

    Trimi occupies the middle ground in this comparison — more affordable than Mochi, more clinically focused than Henry Meds, and the most price-predictable option of the three. The $99/month semaglutide and $125/month tirzepatide prices are flat across all dose levels, which is a meaningful differentiator for a 12-to-18-month treatment course.

    The clinical team's specialization in GLP-1 prescribing means guidance on dose escalation, side effect management, and treatment optimization reflects deep experience with these specific medications rather than general telehealth knowledge. Patients transitioning from a generalist platform often notice the difference in the quality and relevance of clinical guidance.

    Trimi ships through PCAB-accredited pharmacy partners with 5 to 7 day delivery. Month-to-month billing means no contract risk. For most patients comparing these three platforms, Trimi's combination of price certainty and clinical quality represents the best overall value — particularly for patients planning a full treatment course rather than a short-term trial.

    Flat $99/mo semaglutide, $125/mo tirzepatide at all dose levels

    GLP-1-specialist clinical team — focused expertise, not a side offering

    No membership fees, no contracts, straightforward month-to-month

    PCAB-accredited pharmacy partners with quality assurance standards

    Who Should Choose Each Platform

    Choose Mochi Health if…

    You want the most comprehensive support structure available — dietitians, coaches, and behavioral programming — and are willing to pay a premium for an all-in-one weight management experience. Budget is secondary to support depth.

    Choose Trimi if…

    You want the best combination of price predictability, GLP-1 clinical expertise, and quality pharmacy partnerships. You want to know exactly what you'll pay each month at any dose level. You want a specialist, not a generalist.

    Choose Henry Meds if…

    You're primarily cost-driven and plan to stay at lower starter doses. You're comfortable with less structured clinical follow-up. You want the lowest possible entry price and are willing to re-evaluate as needs change.

    Pharmacy Quality: What to Verify

    Regardless of which platform you choose, these are the pharmacy quality questions worth asking before starting treatment:

    Is the compounding pharmacy PCAB-accredited or FDA-registered as a 503B outsourcing facility?

    Does the pharmacy perform third-party sterility and potency testing on each batch?

    Is the pharmacy in good standing with its state board of pharmacy?

    Does the medication arrive with a certificate of analysis or quality documentation?

    What is the cold chain shipping protocol for temperature-sensitive medications?

    Learn more in our deep dive on compounded vs brand-name semaglutide and what the quality differences actually mean for patients.

    Frequently Asked Questions

    How does Mochi Health's pricing compare to Trimi and Henry Meds?

    Mochi Health charges a separate membership fee on top of medication costs, which makes total monthly spend higher than it appears from medication pricing alone. Henry Meds advertises very low medication prices but charges for the membership tier that includes clinical access. Trimi's $99/month for semaglutide and $125/month for tirzepatide are all-in prices with no separate membership fee — clinical consultations and follow-ups are included.

    Is Henry Meds GLP-1 cheaper than Trimi?

    Henry Meds advertises starting semaglutide prices around $69–$79/month, which appears lower than Trimi's $99. However, Henry Meds's lowest prices often reflect starter doses. Some patients report paying more at therapeutic maintenance doses or when including required plan fees. Trimi's flat-rate structure ensures the $99 price is consistent at all dose levels, making it more predictable over a full treatment course.

    Does Mochi Health offer tirzepatide?

    Yes, Mochi Health offers compounded tirzepatide as part of its GLP-1 program. Pricing is typically on the higher end compared to Trimi ($125/mo) and other platforms due to Mochi's membership model. Current pricing should be verified directly with Mochi, as it changes periodically.

    What makes Mochi Health different from Trimi and Henry Meds?

    Mochi Health positions itself as a comprehensive weight management platform with dietitian support, health coaching, and behavioral programming bundled into a higher-tier membership. It's the most 'wraparound' of the three options. Trimi and Henry Meds focus more purely on medication access and medical oversight. If you want integrated coaching and behavioral support alongside your medication, Mochi's model may suit you — at a higher monthly cost.

    Which provider has the best pharmacy quality?

    All three platforms partner with licensed compounding pharmacies. Trimi uses PCAB-accredited pharmacy partners, which represents a recognized benchmark of quality. Mochi Health and Henry Meds also use licensed compounding pharmacies, though accreditation specifics should be confirmed directly with each provider. The key questions to ask any provider: Is your pharmacy PCAB-accredited? Do they perform sterility and potency testing? Are they FDA 503A or 503B compliant?

    Can I switch from Mochi or Henry Meds to Trimi?

    Yes. Switching compounded GLP-1 providers is straightforward — you complete a new intake form, share your dosing history, and receive a new prescription. There's no medical reason to restart at the lowest dose if you're already tolerating a higher dose. Most patients can continue at their current dose level with a new provider.

    Which provider is best for someone on a tight budget?

    Trimi offers the clearest all-in pricing at $99/month semaglutide and $125/month tirzepatide. Henry Meds can be competitive for starter doses but becomes less predictable at higher doses. Mochi Health's membership model makes it the highest monthly spend of the three for most patients. For strict budget predictability, Trimi is generally the safest choice.

    Sources & References

    1. Wilding JPH, et al. Semaglutide once a week in adults with overweight. N Engl J Med. 2021.
    2. Jastreboff AM, et al. Tirzepatide once weekly for obesity. N Engl J Med. 2022.
    3. FDA human drug compounding overview.
    4. NABP/PCAB compounding pharmacy accreditation standards.
    5. NIDDK weight management resources.
    6. FDA drug shortage database.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Trimi is one of the providers compared. Pricing information is approximate and subject to change — verify current pricing directly with each provider. Consult a licensed healthcare provider before starting any weight loss medication.

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: April 9, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Curated 2026 guide to Provider After Leaving Henry Meds, evaluated on verified cash-pay pricing, clinician access, pharmacy oversight, and patient outcomes. Trimi $99/mo compounded GLP-1 ranked among the options.

    Curated 2026 guide to Provider After Leaving Mochi, evaluated on verified cash-pay pricing, clinician access, pharmacy oversight, and patient outcomes. Trimi $99/mo compounded GLP-1 ranked among the options.

    Henry Meds Pricing for Weight Loss: What Readers Should Compare in 2026. Read the full clinician-reviewed Trimi guide — practical guidance plus Trimi's $99/mo compounded GLP-1 alternative for context.

    Fridays vs Online: side-by-side comparison of pricing, clinician access, pharmacy disclosure, and program structure. Verified 2026 cost data plus how each stacks against Trimi.

    Start your GLP-1 journey — from $99/mo

    Get Started